Literature DB >> 7018851

Diffusion of ceftriaxone (Ro 13-9004/001) in the cerebrospinal fluid. Comparison with other beta-lactam antibiotics in dogs with healthy meninges and in dogs with experimental meningitis.

B Marchou, M Armengaud.   

Abstract

After i.v injection of 50 and 100 mg/kg ceftriaxone in 1 h in dogs with healthy meninges, the cerebrospinal fluid (CSF) concentrations found between minutes 90 and 240 were an average of 0.37 (0.32-0.41) and 1.22 microgram/ml (1.02-1.56), respectively. In dogs with meningitis a dosage of 50 mg/kg yielded high concentrations from minutes 60 to 240: on average, 13.0 microgram/ml (9.9-14.9); 9.9 microgram/ml in the fourth hour. The concentrations obtained in dogs with healthy meninges were 10-100 times higher than the MICs for meningococci and Haemophilus influenzae. In the infected dogs, the concentrations obtained were enough to eliminate virtually all the bacteria responsible for meningitis (except Mycobacterium tuberculosis). In the dogs with healthy meninges, the ratio of the CSF/plasma AUCs was 0.61% after 50 mg/kg, and 1.00% after 100 mg/kg. In the infected dogs, this ratio was 22.4% after 50 mg/kg. Comparison of the ratio of AUCs obtained under ceftriaxone with that under other beta-lactam antibiotics shows the former to be one of the highest.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7018851     DOI: 10.1159/000238027

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  13 in total

1.  Cefotaxime versus penicillin in the late stage of Lyme disease--prospective, randomized therapeutic study.

Authors:  D Hassler; L Zöller; M Haude; H D Hufnagel; F Heinrich; H G Sonntag
Journal:  Infection       Date:  1990 Jan-Feb       Impact factor: 3.553

2.  Short course single daily ceftriaxone monotherapy for acute bacterial meningitis in children: results of a Swiss multicenter study. Part I: Clinical results.

Authors:  E Martin; P Hohl; T Guggi; F H Kayser; M Fernex
Journal:  Infection       Date:  1990 Mar-Apr       Impact factor: 3.553

Review 3.  Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  D M Richards; R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-06       Impact factor: 9.546

4.  Ceftriaxone diffusion into cerebrospinal fluid of children with meningitis.

Authors:  R Latif; A S Dajani
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

5.  Comparison of the activities of ceftriaxone and penicillin G against experimentally induced syphilis in rabbits.

Authors:  R C Johnson; R F Bey; S J Wolgamot
Journal:  Antimicrob Agents Chemother       Date:  1982-06       Impact factor: 5.191

6.  Ceftriaxone: in vitro studies and clinical evaluation.

Authors:  J W Gnann; W E Goetter; A M Elliott; C G Cobbs
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191

7.  Single-dose pharmacokinetics of ceftriaxone in infants and young children.

Authors:  U B Schaad; K Stoeckel
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191

Review 8.  Clinical pharmacokinetics of the third generation cephalosporins.

Authors:  L Balant; P Dayer; R Auckenthaler
Journal:  Clin Pharmacokinet       Date:  1985 Mar-Apr       Impact factor: 6.447

Review 9.  Clinical pharmacokinetics of ceftriaxone.

Authors:  J H Yuk; C H Nightingale; R Quintiliani
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

Review 10.  Rationale for optimal dosing of beta-lactam antibiotics in therapy for bacterial meningitis.

Authors:  W M Scheld
Journal:  Eur J Clin Microbiol       Date:  1984-12       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.